147 related articles for article (PubMed ID: 15155278)
1. Antisense oligodeoxynucleotides directed against a novel angiotensinogen mRNA-stabilizing protein reduce blood pressure in spontaneously hypertensive rats.
Klett CP; Anderson D; Sholook M; Granger JP
Am J Physiol Regul Integr Comp Physiol; 2004 Sep; 287(3):R619-26. PubMed ID: 15155278
[TBL] [Abstract][Full Text] [Related]
2. Reduction of plasma angiotensin II to normal levels by antisense oligodeoxynucleotides against liver angiotensinogen cannot completely attenuate vascular remodeling in spontaneously hypertensive rats.
Sugano M; Tsuchida K; Sawada S; Makino N
J Hypertens; 2000 Jun; 18(6):725-31. PubMed ID: 10872557
[TBL] [Abstract][Full Text] [Related]
3. Intravenous injection with antisense oligodeoxynucleotides against angiotensinogen decreases blood pressure in spontaneously hypertensive rats.
Makino N; Sugano M; Ohtsuka S; Sawada S
Hypertension; 1998 May; 31(5):1166-70. PubMed ID: 9576130
[TBL] [Abstract][Full Text] [Related]
4. Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin.
Gyurko R; Wielbo D; Phillips MI
Regul Pept; 1993 Dec; 49(2):167-74. PubMed ID: 8134617
[TBL] [Abstract][Full Text] [Related]
5. Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
Wagner J; Drab M; Bohlender J; Amann K; Wienen W; Ganten D
Clin Exp Hypertens; 1998 Feb; 20(2):205-21. PubMed ID: 9533614
[TBL] [Abstract][Full Text] [Related]
6. Training-induced pressure fall in spontaneously hypertensive rats is associated with reduced angiotensinogen mRNA expression within the nucleus tractus solitarii.
Felix JV; Michelini LC
Hypertension; 2007 Oct; 50(4):780-5. PubMed ID: 17646572
[TBL] [Abstract][Full Text] [Related]
7. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen.
Tomita N; Morishita R; Higaki J; Aoki M; Nakamura Y; Mikami H; Fukamizu A; Murakami K; Kaneda Y; Ogihara T
Hypertension; 1995 Jul; 26(1):131-6. PubMed ID: 7541778
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hypertension by peripheral administration of antisense oligodeoxynucleotides.
Wielbo D; Simon A; Phillips MI; Toffolo S
Hypertension; 1996 Jul; 28(1):147-51. PubMed ID: 8675256
[TBL] [Abstract][Full Text] [Related]
10. Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats.
Makino N; Sugano M; Ohtsuka S; Sawada S; Hata T
Cardiovasc Res; 1999 Dec; 44(3):543-8. PubMed ID: 10690286
[TBL] [Abstract][Full Text] [Related]
11. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats.
Yoneda M; Sanada H; Yatabe J; Midorikawa S; Hashimoto S; Sasaki M; Katoh T; Watanabe T; Andrews PM; Jose PA; Felder RA
Hypertension; 2005 Jul; 46(1):58-65. PubMed ID: 15956107
[TBL] [Abstract][Full Text] [Related]
13. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
[TBL] [Abstract][Full Text] [Related]
14. Blood Pressure Lowering and Safety Improvements With Liver Angiotensinogen Inhibition in Models of Hypertension and Kidney Injury.
Mullick AE; Yeh ST; Graham MJ; Engelhardt JA; Prakash TP; Crooke RM
Hypertension; 2017 Sep; 70(3):566-576. PubMed ID: 28716988
[TBL] [Abstract][Full Text] [Related]
15. Angiotensinogen messenger RNA stabilization by angiotensin II.
Klett CP; Printz MP; Bader M; Ganten D; Eggena P
J Hypertens Suppl; 1996 Dec; 14(5):S25-36. PubMed ID: 9120681
[TBL] [Abstract][Full Text] [Related]
16. Antisense inhibition of hypertension in the spontaneously hypertensive rat.
Wielbo D; Sernia C; Gyurko R; Phillips MI
Hypertension; 1995 Mar; 25(3):314-9. PubMed ID: 7875755
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
Benter IF; Yousif MH; Anim JT; Cojocel C; Diz DI
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H684-91. PubMed ID: 16403946
[TBL] [Abstract][Full Text] [Related]
18. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
[TBL] [Abstract][Full Text] [Related]
19. Blunted renal responses to angiotensin II infusion in lifetime captopril-treated spontaneously hypertensive rats.
Wu JN; Tsai SY; Hsieh WY
Chin J Physiol; 2001 Jun; 44(2):59-65. PubMed ID: 11530945
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II.
Schunkert H; Ingelfinger JR; Jacob H; Jackson B; Bouyounes B; Dzau VJ
Am J Physiol; 1992 Nov; 263(5 Pt 1):E863-9. PubMed ID: 1443118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
